AlphaCrest Capital Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

AlphaCrest Capital Management’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,999	Closed	-$376K	–	1362
2020 Q4	$376K	Buy	+2,999	New	+$335K	0.03%	810
2020 Q3	–	Sell	-3,590	Closed	-$349K	–	1231
2020 Q2	$349K	Sell	3,590 -3,767	-51%	-$351K	0.06%	560
2020 Q1	$611K	Sell	7,357 -1,343	-15%	-$131K	0.07%	478
2019 Q4	$967K	Sell	8,700 -7,600	-47%	-$782K	0.08%	366
2019 Q3	$1.62M	Buy	+16,300	New	+$1.62M	0.1%	325
2019 Q2	–	Sell	-2,400	Closed	-$265K	–	1176
2019 Q1	$265K	Buy	+2,400	New	+$251K	0.04%	694

Other funds holding PRAH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AlphaCrest Capital Management's PRAH Position: Q1 2021 in Review

AlphaCrest Capital Management sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2021, closing a stake of 2,999 shares — an estimated $376K sold.

AlphaCrest Capital Management first reported a position in PRAH in Q1 2019 and held it in 6 quarters. The position peaked at $1.62M in Q3 2019. 324 funds tracked by Wall St. Rank hold PRAH as of Q1 2021.

AlphaCrest Capital Management reported no remaining PRA Health Sciences, Inc. position as of Q1 2021 after selling out during the quarter.
AlphaCrest Capital Management sold 2,999 PRA Health Sciences, Inc. shares in Q1 2021, an estimated $376K.
AlphaCrest Capital Management first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 6 quarters.
AlphaCrest Capital Management's PRA Health Sciences, Inc. position peaked at $1.62M in Q3 2019.
324 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2021.

Based on AlphaCrest Capital Management's 13F filing for Q1 2021, filed 13 May 2021.